NYSE:INSP • US4577301090
The current stock price of INSP is 62.99 USD. Today INSP is up by 0.85%. In the past month the price decreased by -3.98%. In the past year, price decreased by -65.63%.
ChartMill assigns a technical rating of 0 / 10 to INSP. When comparing the yearly performance of all stocks, INSP is a bad performer in the overall market: 96.37% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to INSP. INSP has an excellent financial health rating, but there are some minor concerns on its profitability.
On February 11, 2026 INSP reported an EPS of 1.62 and a revenue of 269.08M. The company beat EPS expectations (81.33% surprise) and missed revenue expectations (-0.7% surprise).
25 analysts have analysed INSP and the average price target is 95.55 USD. This implies a price increase of 51.69% is expected in the next year compared to the current price of 62.99.
For the next year, analysts expect an EPS growth of -29.76% and a revenue growth 7.01% for INSP
Over the last trailing twelve months INSP reported a non-GAAP Earnings per Share(EPS) of 2.51. The EPS increased by 45.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.05% | ||
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| Debt/Equity | 0 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.08 | 193.084B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.96 | 176.393B | ||
| SYK | STRYKER CORP | 24.11 | 141.687B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.37 | 108.246B | ||
| IDXX | IDEXX LABORATORIES INC | 41.06 | 49.421B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.46 | 48.681B | ||
| BDX | BECTON DICKINSON AND CO | 10.61 | 48.418B | ||
| RMD | RESMED INC | 20.59 | 37.195B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.79 | 35.143B | ||
| DXCM | DEXCOM INC | 26.97 | 27.57B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.99 | 18.52B | ||
| PODD | INSULET CORP | 37.39 | 16.95B | ||
| HOLX | HOLOGIC INC | 15.05 | 16.91B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The company is headquartered in Golden Valley, Minnesota and currently employs 1,333 full-time employees. The company went IPO on 2018-05-03. The firm is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The firm sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
INSPIRE MEDICAL SYSTEMS INC
5500 Wayzata Blvd Ste 1600
Golden Valley MINNESOTA 55416 US
CEO: TimothyP. Herbert
Employees: 1333
Phone: 17639575037
Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The company is headquartered in Golden Valley, Minnesota and currently employs 1,333 full-time employees. The company went IPO on 2018-05-03. The firm is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The firm sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
The current stock price of INSP is 62.99 USD. The price increased by 0.85% in the last trading session.
INSP does not pay a dividend.
INSP has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
25 analysts have analysed INSP and the average price target is 95.55 USD. This implies a price increase of 51.69% is expected in the next year compared to the current price of 62.99.
INSPIRE MEDICAL SYSTEMS INC (INSP) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
INSPIRE MEDICAL SYSTEMS INC (INSP) has a market capitalization of 1.80B USD. This makes INSP a Small Cap stock.